Medics in the UK have become the first in the world to successfully administer a pioneering gene therapy that preserves sight in young children with an extremely rare genetic condition that usually causes blindness in the first few years of life.
The patients, who were essentially blind at birth, can now see shapes, find toys, recognise faces, and in some cases, can even read and write.
